October 15-18 marked the annual International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer (WCLC). Oncologists from over 100 countries came together in Japan to discuss the latest developments and findings related to thoracic malignancy research.
JCP staff were on hand to cover the meeting and engage with stakeholders throughout the weekend. We encourage all who are able to attend next year’s CPC, which will be held October 26-28, 2018, in Boston, MA.
September 24-27 marked the annual American Society for Radiation Oncology (ASTRO) meeting. Radiation oncologists came together in San Diego, California to discuss the latest research and findings related to radiation therapy. Journal of Clinical Pathways has provided some of the most relevant discussions from this meeting.
September 8-12 marked the annual European Society for Medical Oncology (ESMO) Congress. Cancer researchers and clinicians came together in Madrid, Spain to enable collaboration and the exchange of important ideas in oncology. Journal of Clinical Pathways has provided some of the most relevant discussions from the congress.
September 8-10 marked the second annual Clinical Pathways Congress. Leading experts in pathway development, implementation, and evaluation convened in Washington, DC to discuss these and other hot topics related to oncology clinical pathways.
The ASCO Annual Meeting is undoubtedly the premier gathering of oncology professionals from the United States and abroad, and a fertile ground for the presentation of scientific advances throughout the field.
Journal of Clinical Pathways provides highlights from the Academy of Managed Care Pharmacy Annual Meeting in Denver, Colorado (March 27-30, 2017).
Journal of Clinical Pathways provides highlights from the American Society of Clinical Oncology Quality Care Symposium in Orlando, Florida (March 3-4, 2017).
Journal of Clinical Pathways provides highlights from the annual Cancer Survivorship Summit in San Diego, California (January 27-28, 2017).
Many young adult cancer survivors are unaware of potential long-term adverse effects of cancer therapies and of the necessity of follow-up care.